A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety & Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/07 → 12/31/14